[Guidelines for the radiotherapy of gliomas].
Fiche publication
Date publication
septembre 2016
Journal
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Auteurs
Membres identifiés du Cancéropôle Est :
Pr ANTONI Delphine, Pr NOEL Georges, Pr TRUC Gilles
Tous les auteurs :
Feuvret L, Antoni D, Biau J, Truc G, Noël G, Mazeron JJ
Lien Pubmed
Résumé
Gliomas are the most frequent primary brain tumours. Treating these tumours is difficult because of the proximity of organs at risk, infiltrating nature, and radioresistance. Clinical prognostic factors such as age, Karnofsky performance status, tumour location, and treatments such as surgery, radiation therapy, and chemotherapy have long been recognized in the management of patients with gliomas. Molecular biomarkers are increasingly evolving as additional factors that facilitate diagnosis and therapeutic decision-making. These practice guidelines aim at helping in choosing the best treatment, in particular radiation therapy.
Mots clés
Age Factors, Aged, Central Nervous System Neoplasms, diagnostic imaging, Combined Modality Therapy, Cranial Irradiation, adverse effects, Dose Fractionation, Glioblastoma, radiotherapy, Glioma, diagnostic imaging, Humans, Middle Aged, Organs at Risk, Radiation Injuries, prevention & control, Radiotherapy Dosage
Référence
Cancer Radiother. 2016 Sep;20 Suppl:S69-79